Apogee Therapeutics APGE 深 滬
已收盤 08-07 16:00:00 美东时间
134.84
+0.350
+0.26%
華盛通- 最 高134.88
- 今 開134.65
- 成交量 149.52万股
- 最 低 134.47
- 昨 收 134.49
- 總市值 101.98亿
- 52周最高 134.88
- 市盈率 靜 --
- 換手率 1.98%
- 52周最低 35.39
- 委 比 -17.44%
- 總股本 7562.68万
- 歷史最高 134.88
- 量 比 0.89
- 振 幅 0.30%
- 歷史最低 14.19
- 每 手 1
- 風險率 27.80%
個股概要
財務分析
公司資料
相關新聞
分紅派息
- 分時圖
- 日k
- 周k
- 月k
相關新聞
更多Are DSGR, AVB, SLP, APGE Obtaining Fair Deals for their Shareholders?
Insiders may stand to receive substantial financial benefits not available to ordinary shareholders. The proposed transactions may contain terms that could limit superior competing offers. S...
07-31 23:02
艾伯维因收购下调业绩预期，本季度利润大幅攀升
这家制药企业更新全年调整后每股收益预期至 13.87~14.07 美元，此前指引为 13.91~14.11 美元 艾伯维下调全年调整后盈利预期。 ...
07-31 23:00
艾伯维下调业绩展望以反映收购影响，第二季度利润大幅增长
艾伯维下调了全年调整后盈利展望，以反映其对Apogee Therapeutics的收购，该公司近期季度利润和营收均有所增长。 这家制药公司周五表示，拟议中的...
07-31 21:00
艾伯维2026年第二季度财报：免疫学与神经科学推动营收增长10.2%
艾伯维2026年第二季度营收169.90亿美元，同比增长10.2%；GAAP摊薄EPS为2.03美元，调整后EPS为3.65美元，免疫学与神经科学组合成为主要增长来源。
07-31 11:51
AbbVie Earnings Preview: Immunology portfolio remains in focus amid Humira decline
AbbVie (ABBV) is projected to report a solid second-quarter print, with double-digit growth seen for both top and bottom lines. EPS is expected to go up 67% Y/Y to $3.61. This is the higher end of man...
07-31 00:01
Biotech stocks lead healthcare's overbought list as earnings picks up
Healthcare stocks are in focus as second-quarter earnings season shifts into high gear, with investors evaluating whether recent rallies across biotech, medical technology and healthcare services can ...
07-23 19:18
AbbVie granted EU nod for Boey anti-wrinkle therapy
AbbVie (ABBV) unit, Allergan Aesthetics, announced on Friday that the European Commission approved its anti-wrinkle therapy, Boey, for the temporary improvement of glabellar lines, commonly known as f...
07-17 22:05
AbbVie extends slide to a seventh straight session
AbbVie (ABBV) declines 1.30% to $244.78 in Tuesday afternoon trading, on track for its seventh straight session of losses. Over the past six trading sessions, the stock has declined 5.1%, compared wi...
07-15 01:45
百亿美金并购新狂潮背后
原标题：百亿美金并购新狂潮背后 又一笔百亿美元级并购诞生。 7月6日，Vertex宣布以每股85美元、总价约100亿美元的全现金交易，正式将专注于内分泌罕见病...
07-08 10:19
